PAM Theragnostics News and Events

Press releases

1,5 Millionen Euro für neue Alzheimer-Therapie
January 19 2022
Read more →
Brandenburg Kapital investiert in Biotechnologie-Startup zur Bekämpfung der Alzheimer-Demenz
January 18 2022
Read more →

Publications, conferences & talks

Kaufmann et al., 2024, Sandwich immunoassay for adrenomedullin precursor and its practical application
November 15 2024
Read more →
1nd International Virtual Congress on Dementia and Alzheimer's Diseases (DAC), 2024, Peptidylglycine α-amidating monooxygenase as a novel biomarker target for diagnosis and therapy of neurological degenerative conditions
February 15 2024
Read more →
Goetze et al. 2023, Peptidylglycine α-amidating monooxygenase and adrenomedullin measurement in patients with hepatic cirrhosis
September 15 2023
Read more →
Ilina et al. 2023, Immunoassay-based quantification of full-length peptidylglycine alpha-amidating monooxygenase in human plasma
July 03 2023
Read more →
Alzheimer's & Parkinson's Diseases Conference (AD/PD) 2022, "Disrupted adrenomedullin homeostasis as a predictive biomarker for Alzheimer´s disease"
March 15 2022
Read more →
Kaufmann et al. 2021, Novel insights into peptide amidation and amidating activity in the human circulation
August 16 2021
Read more →
Older Publications, conferences & talks →